| Realtime | Geld | Brief | Zeit |
|---|---|---|---|
| 0,896 | 0,924 | 11:34 |
| Zeit | Aktuelle Nachrichten Sprache:
Alle DE EN | Leser | Medien | ||
|---|---|---|---|---|---|
| 21.08. | Mentice AB: Mentice receives approximately SEK 31.95 million through oversubscribed rights issue | 113 | GlobeNewswire (Europe) | THIS PRESS RELEASE MAY NOT BE MADE PUBLIC, PUBLISHED OR DISTRIBUTED, DIRECTLY OR INDIRECTLY, IN OR INTO THE UNITED STATES OF AMERICA, AUSTRALIA, BELARUS, HONG KONG, JAPAN, CANADA, NEW ZEALAND, RUSSIA... ► Artikel lesen | |
| 01.08. | Mentice AB: Mentice receives an additional Subscription Commitment of 3.4 MSEK in the upcoming Rights Issue | 120 | GlobeNewswire (Europe) | THIS PRESS RELEASE MAY NOT BE MADE PUBLIC, PUBLISHED OR DISTRIBUTED, DIRECTLY OR INDIRECTLY, IN OR INTO THE UNITED STATES OF AMERICA, AUSTRALIA, BELARUS, HONG KONG, JAPAN, CANADA, NEW ZEALAND, RUSSIA... ► Artikel lesen | |
| 31.07. | XFRA CAPITAL ADJUSTMENT INFORMATION - 31.07.2025 | 242 | Xetra Newsboard | Das Instrument MN2 SE0012673291 MENTICE AB SK -,20 EQUITY wird ex Kapitalmassnahme gehandelt am 31.07.2025 The instrument MN2 SE0012673291 MENTICE AB SK -,20 EQUITY is traded ex capital adjustment on... ► Artikel lesen | |
| 24.07. | Mentice AB: Schwäche im APAC-Geschäft belastet Q2-Ergebnis und Aktie | 1 | Investing.com Deutsch | ||
| 24.07. | Mentice AB: Mentice resolves on a rights issue of approximately SEK 31.95 million | 180 | GlobeNewswire (Europe) | The Board of Directors of Mentice AB (publ) ("Mentice" or the "Company"), (Nasdaq First North Premium Growth Market) has today, based on the authorization granted by the annual general meeting on 27... ► Artikel lesen | |
| 24.07. | Mentice AB: Mentice publishes the company's interim report for the period April-June 2025 | 138 | GlobeNewswire (Europe) | IMPORTANT STRATEGIC STEPS TAKEN
SIGNIFICANT EVENTS DURING THE SECOND QUARTER 2025 (APR - JUN)Mentice announced a strategic workforce realignment aimed at optimizing its organizational structure and... ► Artikel lesen | |
| 11.07. | Mentice AB: Mentice AB Announces Consolidation of Physical Simulation Operations to Strengthen Long-Term Efficiency and Global Service Delivery | 271 | GlobeNewswire (Europe) | Gothenburg, Sweden, July 11, 2025 - Mentice AB (publ), a global leader in simulation solutions for image-guided therapies, today announces the decision to consolidate its research and development (R&D)... ► Artikel lesen | |
| MENTICE Aktie jetzt für 0€ handeln | |||||
| 16.06. | Mentice AB: Mentice AB announces the intent for a strategic workforce realignment to enhance focus and operational efficiency and the intent for a rights issue of max 10% of the share capital | 185 | GlobeNewswire (Europe) | Mentice AB (publ), a globally recognized leader in simulation solutions for image-guided interventional therapies, today announces the intent of a strategic workforce realignment and the intent of planning... ► Artikel lesen | |
| 09.05. | MENTICE AB: Mentice's CEO to "We anticipate a further ramp up in our sales" | 1 | Cision News | ||
| 08.05. | Mentice AB: Mentice publishes the company's interim report for the period January-March 2025 | 132 | GlobeNewswire (Europe) | STABLE GROWTH AND STRATEGIC CHANGES IN THE FIRST QUARTER
SIGNIFICANT EVENTS DURING THE FIRST QUARTER 2025 (JAN - MAR)Mentice announced a significant order from a top 20 global Med Tech company for 6.5... ► Artikel lesen | |
| 07.05. | MENTICE AB: Mentice launches Ankyras in Brazil | 1 | Cision News | ||
| 17.04. | Mentice AB: Mentice AB Publishes Annual and Sustainability Report for 2024 - Strong finish to 2024 following a transitional year | 188 | GlobeNewswire (Europe) | Mentice AB (publ), Gothenburg - a globally recognized leader in simulation solutions for image-guided interventional therapies, today published its Annual Report and Sustainability Report for 2024.
The... ► Artikel lesen | |
| 13.02. | Mentice AB: Mentice publishes the company's year-end report for the period January-December 2024 | 149 | GlobeNewswire (Europe) | STRONG CLOSING QUARTER
SIGNIFICANT EVENTS DURING THE FORTH QUARTER 2024 (OCT - DEC)Mentice announced the recruitment of Frans Venker as new CEO, starting Jan 1, 2025.The order intake during the quarter... ► Artikel lesen | |
| 03.02. | Research and Markets: Europe Surgical Robotics Simulation Market Research 2024-2033, Profiles of Fundamental Surgery, Metall-Zug, Mentice, Surgical Science Sweden, VirtaMed, VOXEL-MAN - ResearchAndMarkets.com | 500 | Business Wire | The "Europe Surgical Robotics Simulation Market: Analysis and Forecast, 2024-2033" report has been added to ResearchAndMarkets.com's offering.
The Europe surgical robotics simulation market was... ► Artikel lesen | |
| 28.11.24 | Mentice AB: Announcement of New CEO Appointment | 438 | GlobeNewswire (Europe) | Mentice (publ), Gothenburg, a globally recognized leader in simulation solutions for image-guided interventional therapies, announced today the appointment of Frans Venker as its new Chief Executive... ► Artikel lesen | |
| 07.11.24 | Mentice AB: Mentice publishes the company's interim report for the period July - September 2024 | 210 | GlobeNewswire (Europe) | A challenging summer quarter at the level of last year
SIGNIFICANT EVENTS DURING THE THIRD QUARTER 2024 (JUL - SEP)Mentice and AGIK, the Working Group of Interventional Cardiology within the German... ► Artikel lesen |
| Unternehmen / Aktien | Aktienkurs | % | Top-Nachrichten | ||
|---|---|---|---|---|---|
| ECKERT & ZIEGLER | 17,020 | -2,18 % | Eckert & Ziegler-Aktie im Mittelpunkt - Experten erwarten bald starke Reaktion! | ||
| PENUMBRA | 214,00 | +0,47 % | Penumbra study backs mechanical thrombectomy for treating pulmonary embolism | ||
| FRESENIUS | 49,790 | +0,81 % | Still und heimlich aufwärts - Bayer, Fresenius, NetraMark Holdings | Die Biotechnologie hat in den letzten Jahrzehnten enorme Durchbrüche erzielt, so im Bereich der Geneditierung, der synthetischen Biologie aber auch bei der Individualisierung der Medizin. Durch das... ► Artikel lesen | |
| SIEMENS HEALTHINEERS | 49,280 | -0,40 % | EQS-CMS: Siemens Healthineers AG: Veröffentlichung einer Kapitalmarktinformation | EQS Zulassungsfolgepflichtmitteilung: Siemens Healthineers AG
/ Bekanntmachung nach Art. 5 Abs. 1 lit. b), Abs. 3 der Verordnung (EU) Nr. 596/2014, zuletzt geändert durch die Verordnung... ► Artikel lesen | |
| BRIGHTSPRING HEALTH SERVICES | 33,800 | 0,00 % | A Look at BrightSpring Health's Upcoming Earnings Report | ||
| KINDLY MD | 1,020 | 0,00 % | KindlyMD, Inc: KindlyMD Announces Strategic Partnership with Antalpha and Intent to Establish $250 Million Convertible Debt Facility | First Step in Broader Effort to Develop Innovative Financing Tools for the Bitcoin MarketCollaboration Launches Initial Treasury Financing Structure SALT LAKE CITY, UTAH / ACCESS Newswire / October... ► Artikel lesen | |
| GENEDX | 130,66 | 0,00 % | GeneDx Holdings Corp. Q3 2025 Earnings Preview | ||
| UNITEDHEALTH | 325,05 | +3,03 % | Nächstes Beben: Molina Healthcare crasht - UnitedHealth schwach | Die US-Krankenversicherer kommen nicht zur Ruhe. Am Mittwochabend hat der Gesundheitsdienstleister Molina Healthcare die Anleger mit enttäuschenden Zahlen erneut verunsichert. Die Aktie brach daraufhin... ► Artikel lesen | |
| GERRESHEIMER | 29,080 | -1,09 % | Gerresheimer: Jetzt auf die Trendwende setzen? | Der Spezialverpackungshersteller räumt erstmals Verstöße gegen Rechnungslegungsvorschriften ein - und verspricht Aufklärung. Die Aktie reagiert erleichtert. Ist das die Trendwende bei der gebeutelten... ► Artikel lesen | |
| ALIGNMENT HEALTHCARE | 17,760 | 0,00 % | Alignment Healthcare USA, LLC: Alignment Health Plan Joins Forces with Suvida Healthcare to Expand Bilingual Care, Access for Arizona Seniors | ||
| PROCEPT BIOROBOTICS | 36,340 | 0,00 % | PROCEPT BioRobotics Reports Second Quarter 2025 Financial Results and Increases 2025 Revenue Guidance | SAN JOSE, Calif., Aug. 06, 2025 (GLOBE NEWSWIRE) -- PROCEPT BioRobotics® Corporation (Nasdaq: PRCT) (the "Company"), a surgical robotics company focused on advancing patient care by developing transformative... ► Artikel lesen | |
| FRESENIUS MEDICAL CARE | 46,660 | -0,06 % | Branicks, CTS Eventim, FMC, Norma Group, Puma, Zalando - Aktien-Positionen der Short-Seller | Wer Aktien leerverkauft, also auf fallende Kurse spekuliert (Shortselling), unterliegt bestimmten Transparenzpflichten. Aktuelle Meldungen über Leerverkäufe geben Aufschluss darüber. Diese Vorgaben... ► Artikel lesen | |
| CO-DIAGNOSTICS | 0,740 | -10,30 % | Co-Diagnostics stock soars after Saudi Arabia joint venture announcement | ||
| PROGYNY | 19,520 | 0,00 % | Progyny, Inc.: Progyny Expands Global Benefits to Include Pregnancy, Postpartum, and Menopause | Global employers can now empower their workforces with comprehensive women's health benefits, supported by localized expertiseNEW YORK, Oct. 22, 2025. (Nasdaq: PGNY), a global leader in women's health... ► Artikel lesen | |
| NUTEX HEALTH | 129,46 | +3,32 % | Nutex Health, Inc.: Nutex Health Provides Corporate Update | Significant Year-over-Year Growth in Patient Volume and Cash Collections
HOUSTON, Oct. 20, 2025 /PRNewswire/ -- Nutex Health Inc. ("Nutex Health" or the "Company")... ► Artikel lesen |